Catalytic oligonucleotides targeting EGR-1 as potential inhibitors of in-stent restenosis.
This brief review discusses recent strategies targeting the zinc finger transcription factor and immediate-early gene product Egr-1 with catalytic DNA in efforts to inhibit postangioplasty restenosis.